Heron Therapeutics Inc (NASDAQ:HRTX)

14.22
Delayed Data
As of Mar 27
 +0.23 / +1.64%
Today’s Change
6.51
Today|||52-Week Range
16.49
+41.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-11.8M-23.3M-55.3M--
 
 
 
 
Depreciation179.0K197.0K333.0K--
 
 
 
 
Total Other Cash Flow2.4M5.0M11.4M--
 
 
 
 
Funds From Operations-9.3M-18.1M-43.5M--
 
 
 
 
Funds From/For Other Operating Expenses-1.5M-1.1M-2.8M--
 
 
 
 
Net Cash Flow - Operating Activities-7.7M-17.0M-40.8M--
 
 
 
 
 
InvestingCapital Expenditures-513.0K-972.0K-1.7M--
 
 
 
 
Net Cash Flow Investing-513.0K-972.0K-1.7M--
 
 
 
 
 
FinancingShort Term Borrowings0.003.0M0.00--
 
 
Long Term Borrowings1.3M0.000.00--
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale22.8M50.5M61.2M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing24.1M53.5M61.2M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash15.9M35.5M18.8M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account